Scarica l'app Stockscreener
1.50
0.00%
0.00
Precedente Chiudi:
$1.50
Aprire:
$1.49
Volume 24 ore:
36,349
Relative Volume:
0.47
Capitalizzazione di mercato:
$4.78M
Reddito:
$1.22M
Utile/perdita netta:
$-22.43M
Rapporto P/E:
-1.2971
EPS:
-1.1564
Flusso di cassa netto:
$-18.78M
1 W Prestazione:
-13.29%
1M Prestazione:
-38.78%
6M Prestazione:
-85.29%
1 anno Prestazione:
-82.12%
Intervallo 1D:
$1.42
$1.53
Intervallo di 1 settimana:
$1.31
$1.7097
Portata 52W:
$1.31
$12.30
Longeveron Inc Stock (LGVN) Company Profile
Nome
Longeveron Inc
Settore
Industria
Telefono
305-302-7158
Indirizzo
1951 NW 7TH AVENUE, MIAMI
Compare LGVN vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
1.50 | 4.78M | 1.22M | -22.43M | -18.78M | -1.1564 |
VRTX
Vertex Pharmaceuticals Inc
|
516.56 | 130.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
248.38 | 99.16B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
802.91 | 82.66B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
880.09 | 55.35B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
386.14 | 43.68B | 5.76B | 514.49M | 1.10B | 4.4813 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
Longeveron Inc Borsa (LGVN) Ultime notizie
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares and Convertible Senior Notes - Investing News Network
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes - Investing News Network
Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes - Investing News Network
Longeveron CEO Stephen H. Willard Discloses RSU Tax Withholding Share Disposal - Kalkine Media
Longeveron Inc. (LGVN) Stock Price, News, Quote & History - Yahoo! Finance Canada
A preprint suggests a cell therapy may reduce brain inflammation in Alzheimer’s - Stock Titan
Longeveron Regains Nasdaq Compliance With Minimum Bid Price - The Globe and Mail
192,308 Longeveron (NASDAQ: LGVN) shares sit with one passive fund - Stock Titan
Longeveron Inc. Class A (LGVN) Stock Price & News - Syfe
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming DeadlineLGVN - TMX Newsfile
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
A biotech presentation is set for New York on Sept. 14 - stocktitan.net
Longeveron | 4: Statement of changes in beneficial ownership of securities - Moomoo
Longeveron | 4: Statement of changes in beneficial ownership of securities - Moomoo
Longeveron (LGVN) Gains 2.68% as Shares Hold Above Key Support at $6.55Breakout Confirmation - vinanet.vn
Longeveron (LGVN) Gains 2.68% as Shares Hold Above Key Support at $6.55Option Breadth - dars.gov.et
Longeveron To Carry Out 1-for-10 Reverse Stock Split On August 27th, 2026 - Moomoo
Longeveron Announces 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance - Intellectia AI
Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday - Sahm
Longeveron Announces 1-for-10 Reverse Stock Split - The National Law Review
Longeveron Announces 1-for-10 Reverse Stock Split - manilatimes.net
Longeveron Announces 1-for-10 Reverse Stock Split - Barchart.com
Longeveron Announces 1-For-10 Reverse Stock Split - TradingView
Longeveron Announces 1-for-10 Reverse Stock Split - Yahoo Finance
Longeveron Announces 1-for-10 Reverse Stock Split - Yahoo Finance
Longeveron Inc. Earnings Call: Trials, Cash and Risk - TipRanks
Longeveron (NASDAQ: LGVN) insider logs new stock trades - Stock Titan
Longeveron (LGVN) grants director 36,000 stock units - Stock Titan
Longeveron (NASDAQ: LGVN) insider reports new stock dealings - Stock Titan
Longeveron (NASDAQ: LGVN) insider reports stock trades - Stock Titan
Longeveron (LGVN) Q2 2026 Earnings Call Transcript - AOL.ca
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - The Manila Times
Longeveron (LGVN) Earnings Reading: Profit Per Share Falls Below Its Benchmark at the Close; After Results: The Stock Gains 4.46% in the Current UpdateProfitability Analysis - vinanet.vn
Longeveron appoints Nirav Jhaveri as chief financial officer - Investing.com Nigeria
Longeveron Appoints Nirav Jhaveri as CFO Ahead of September Trial Data - Minichart
Longeveron (LGVN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Longeveron (LGVN) Q2 2026 Earnings Call Transcript - AOL.com
Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed - TipRanks
Longeveron Appoints New Chief Financial Officer Jhaveri - TipRanks
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - manilatimes.net
Longeveron appoints Nirav Jhaveri as chief financial officer - Investing.com
Longeveron Appoints Nirav Jhaveri As CFO - marketscreener.com
Longeveron appoints Nirav Jhaveri as chief financial officer By Investing.com - Investing.com India
Longeveron Inc. Appoints Nirav Jhaveri as Chief Financial Officer - Quiver Quantitative
Longeveron appoints Nirav Jhaveri as chief financial officer By Investing.com - Investing.com UK
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - Yahoo Finance
September Stem Cell Trial Results Expected as Longeveron Names CFO - Stock Titan
Marie Washburn Net Worth (2026) - GuruFocus
Longeveron reports Q2 EPS (19c) vs. (33c) last year - TipRanks
$Longeveron (LGVN.US)$ - Moomoo
Longeveron Inc Azioni (LGVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.48%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):